These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 30217414)

  • 1. Discovery of DS42450411 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4-aminopyrimidine derivatives.
    Fukuda T; Ishiyama T; Katagiri T; Ueda K; Muramatsu S; Hashimoto M; Aki A; Baba D; Watanabe K; Tanaka N
    Bioorg Med Chem Lett; 2018 Nov; 28(20):3333-3337. PubMed ID: 30217414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of DS28120313 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4,6-disubstituted indazole derivatives.
    Fukuda T; Goto R; Kiho T; Ueda K; Muramatsu S; Hashimoto M; Aki A; Watanabe K; Tanaka N
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5252-5257. PubMed ID: 29079471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and SAR studies of 3,6-disubstituted indazole derivatives as potent hepcidin production inhibitors.
    Fukuda T; Ueda K; Ishiyama T; Goto R; Muramatsu S; Hashimoto M; Watanabe K; Tanaka N
    Bioorg Med Chem Lett; 2017 May; 27(10):2148-2152. PubMed ID: 28377056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of DS79182026: A potent orally active hepcidin production inhibitor.
    Fukuda T; Goto R; Kiho T; Ueda K; Muramatsu S; Hashimoto M; Aki A; Watanabe K; Tanaka N
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3716-3722. PubMed ID: 28705644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation.
    Jain M; Joharapurkar A; Patel V; Kshirsagar S; Sutariya B; Patel M; Patel H; Patel PR
    Eur J Pharmacol; 2019 Jan; 843():113-120. PubMed ID: 30458168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent and selective aminopyrimidine-based B-Raf inhibitors with favorable physicochemical and pharmacokinetic properties.
    Mathieu S; Gradl SN; Ren L; Wen Z; Aliagas I; Gunzner-Toste J; Lee W; Pulk R; Zhao G; Alicke B; Boggs JW; Buckmelter AJ; Choo EF; Dinkel V; Gloor SL; Gould SE; Hansen JD; Hastings G; Hatzivassiliou G; Laird ER; Moreno D; Ran Y; Voegtli WC; Wenglowsky S; Grina J; Rudolph J
    J Med Chem; 2012 Mar; 55(6):2869-81. PubMed ID: 22335519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target identification of hepcidin production inhibitors by a combination of chemical proteomics and radioactive compound binding assay.
    Sasaki M; Ueda K; Fukuda T; Tanaka N; Shimizu H; Kubota K
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2878-2884. PubMed ID: 30139518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.
    Nemeth E; Rivera S; Gabayan V; Keller C; Taudorf S; Pedersen BK; Ganz T
    J Clin Invest; 2004 May; 113(9):1271-6. PubMed ID: 15124018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells.
    Noguchi-Sasaki M; Sasaki Y; Shimonaka Y; Mori K; Fujimoto-Ouchi K
    BMC Cancer; 2016 Apr; 16():270. PubMed ID: 27068103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepcidin Mitigates Renal Ischemia-Reperfusion Injury by Modulating Systemic Iron Homeostasis.
    Scindia Y; Dey P; Thirunagari A; Liping H; Rosin DL; Floris M; Okusa MD; Swaminathan S
    J Am Soc Nephrol; 2015 Nov; 26(11):2800-14. PubMed ID: 25788528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentosan polysulfate to control hepcidin expression in vitro and in vivo.
    Asperti M; Denardo A; Gryzik M; Castagna A; Girelli D; Naggi A; Arosio P; Poli M
    Biochem Pharmacol; 2020 May; 175():113867. PubMed ID: 32088260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia.
    Poli M; Asperti M; Ruzzenenti P; Naggi A; Arosio P
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28397746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys.
    Schwoebel F; van Eijk LT; Zboralski D; Sell S; Buchner K; Maasch C; Purschke WG; Humphrey M; Zöllner S; Eulberg D; Morich F; Pickkers P; Klussmann S
    Blood; 2013 Mar; 121(12):2311-5. PubMed ID: 23349391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of IL-10 on iron metabolism in LPS-induced inflammatory mice via modulating hepcidin expression.
    Huang P; Wang J; Lin X; Yang FF; Tan JH
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3469-3475. PubMed ID: 28829493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Added value of hepcidin quantification for the diagnosis and follow-up of anemia-related diseases.
    Lefebvre T; Lasocki S; Fénéant-Thibault M; Lamy PJ; Cunat S; Ropert-Bouchet M; Aguilar-Martinez P; Lehmann S; Delaby C
    Ann Biol Clin (Paris); 2017 Feb; 75(1):9-18. PubMed ID: 28132948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia.
    Lasocki S; Millot S; Andrieu V; Lettéron P; Pilard N; Muzeau F; Thibaudeau O; Montravers P; Beaumont C
    Crit Care Med; 2008 Aug; 36(8):2388-94. PubMed ID: 18664788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia of inflammation: the cytokine-hepcidin link.
    Andrews NC
    J Clin Invest; 2004 May; 113(9):1251-3. PubMed ID: 15124013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-Propargyl-Cysteine, a Novel Hydrogen Sulfide Donor, Inhibits Inflammatory Hepcidin and Relieves Anemia of Inflammation by Inhibiting IL-6/STAT3 Pathway.
    Wang M; Tang W; Xin H; Zhu YZ
    PLoS One; 2016; 11(9):e0163289. PubMed ID: 27649298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of IL-22 contribution to hepcidin induction and hypoferremia during the response to LPS in vivo.
    Wallace DF; Subramaniam VN
    Int Immunol; 2015 Jun; 27(6):281-7. PubMed ID: 25568302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The iron-regulatory hormone hepcidin: a possible therapeutic target?
    Rochette L; Gudjoncik A; Guenancia C; Zeller M; Cottin Y; Vergely C
    Pharmacol Ther; 2015 Feb; 146():35-52. PubMed ID: 25205158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.